The Chronic Care Policy Alliance sent letters to the House and the Senate urging congressional members to co-sponsor H.R. 7647. This bill would delay the implementation of the 2021 Notice of Benefit and Payment Parameters for one year and reinstate limitations ensuring co-pay assistance counts for brand name drugs that do not have a generic alternative. Policy changes included in the 2021 Notice of Benefit and Payment Parameters jeopardize patient access to medications by threatening manufacturer assistance from counting towards patients’ out-of-pocket maximums. H.R. 7647 will protect patients from facing new and unnecessary barriers to care during the ongoing public health emergency due to the COVID-19 pandemic.